John R. Luderer - Concepedia

Author

John R. Luderer

Penn State Milton S. Hershey Medical Center

Also Known As

J Luderer, JOHN R. LUDERER, John R Luderer, John R. Luderer

Publications

510

Citations

H-Index

Concepts

All Affiliations

Penn State Milton S. Hershey Medical Center Pennsylvania State University

About

John R. Luderer is an author at Penn State Milton S. Hershey Medical Center specializing in medicine, dermatology, and hematology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	4	4	187
2	Public Health	1	1	43
3	Allergy	1	1	43
4	Allergy Medicine	1	1	43
5	Emergency Medicine	1	1	63

John R. Luderer

Publications

354

Citations

H-Index

Page 1

	Year	Citations
The release of thromboxane A2 and prostacyclin following experimental acute pulmonary embolism William C. Reeves, Laurence M. Demers, Mary A. Wood, Prostaglandins Leukotrienes and Medicine Pulmonary EmbolismThrombosisVenous ThrombosisHematologyHemostasis	1983	63
Captopril‐Induced Skin Eruptions John R. Luderer, Donald P. Lookingbill, Dennis W. Schneck, The Journal of Clinical Pharmacology	1982	48
Decreased prevalence of immediate hypersensitivity (atopy) in a cancer population. Joseph C. Allegra, Allan Lipton, Harold H. Harvey, PubMed AsthmaEnvironmental AllergyCancer PopulationAllergy MedicineAllergen	1976	43
Acute renal failure, hemolytic anemia and skin rash associated with captopril therapy John R. Luderer, Anton C. Schoolwerth, Ronald A. Sinicrope, The American Journal of Medicine Drug HypersensitivityGlomerulonephritisAcute Renal FailureHematologySkin Rash	1981	43
Age and ceftriaxone kinetics John R. Luderer, Indravadan H. Patel, J W Durkin, Clinical Pharmacology & Therapeutics	1984	41
Elevated Prostaglandin E in Idiopathic Intestinal Pseudo-Obstruction John R. Luderer, Laurence M. Demers, Eric M. Bonnem, New England Journal of Medicine UrologyFunctional Gastrointestinal DisorderGastroenterologyPathologyPhysical Blockage	1976	38
Dazoxiben, a thromboxane synthetase inhibitor, in Raynaud's phenomenon John R. Luderer, Gary G. Nicholas, Marsha M. Neumyer, Clinical Pharmacology & Therapeutics	1984	25
Effects of nadolol and propranolol on plasma lidocaine clearance Dennis W. Schneck, John R. Luderer, Dwight Davis, Clinical Pharmacology & Therapeutics	1984	23
Converting enzyme inhibition with captopril in patients with primary hyperaldosteronism John R. Luderer, Laurence M. Demers, Timothy S. Harrison, Clinical Pharmacology & Therapeutics	1982	20
Immunosuppression and human cancer: Role of prostaglandins Harold A. Harvey, Joseph C. Allegra, Laurence M. Demers, Cancer	1977	10

Page 1